Health Outcome Differences Between the US and UK

A comparative analysis of the US and UK healthcare systems reveals significant disparities in their structure, funding, and outcomes. Chronic illnesses, including Diabetes, cardiovascular diseases, and respiratory ailments, frequently affect marginalized populations, and this is due to poor healthcare, lack of adequate insurance, and unfavorable social conditions. For example, in the USA, where healthcare consumption was estimated to be about $6719 in 2006, access to care is still uneven, especially for patients who depend on Medicaid or are uninsured (Desai et al., 2019). On the other hand, the UK has a publicly funded national health service known as the National Health Service (NHS), financed by taxes to ensure that all country residents gain access to healthcare regardless of their ability to pay. This elaborate system guarantees that everyone can afford the direct interpersonal cost of free or almost free treatments at the point of use. This includes diabetes management through successive check-ups and prescription of cheap drugs. However, the NHS succeeds in offering equal access to care, which is mitigated by problems like long waits for specialty services, challenges posed by underfunding, and high demand. However, the primary care emphasis of the NHS model differs entirely from the experience of economically disadvantaged people in the US, where access and care outcomes are far from egalitarian.

The US has a costly healthcare system and a mixed insurance system in which private and public systems coexist. According to the statistics, US citizens spent around $6719 on healthcare per capita in 2006, far beyond the UK rate (Desai et al., 2019). However, health care is not easily accessible for most people, especially those in the lower income bracket, who rarely have adequate health insurance. Currently, one in seven Americans is uninsured, which often means that they put off their care, especially if they have chronic illnesses that need constant monitoring and attention to be stable. To manage and redress some of these disparities, the ACA of 2014 expanded the Medicaid program and introduced insurance exchanges. However, there are still some gaps in coverage, and many people with limited financial means need help getting the treatment they need. This lack of access dramatically impacts their health status; due to the expense, they are often unable to seek treatment for their conditions, thereby developing complications and experiencing higher mortality rates for chronic diseases.

In contrast, the UK has a publicly funded healthcare system called the National Health Service. As a social policy, the NHS guarantees that everyone receives medical care regardless of their ability to pay by paying taxes. Free treatment at the point of use defines the work of the NHS and includes comprehensive care for chronic disease. England's NHSS provides outpatient services such as general practitioner visits, inpatient and outpatient hospital care, prescription medicines, and other services at a minimal co-payment by the users. Reducing health literacy through this system removes cost-related factors that may hinder low-income people from maintaining their chronic illnesses (Neter & Brainin, 2019). However, like any other organization, the NHS has its fair share of challenges. Problems of long hours waiting for treatment, staff, and bed deficiencies are ongoing and have been further fueled by the recent underfunding and demand surge. Nevertheless, the efficiency of the NHS in providing low-income people with the needed treatment for chronic diseases and improving the population's health is still notable compared to the US.

Insurance status is a significant predictor of health indicators in the United States of America. Medicaid is a state and federally-funded health insurance program that caters to low-income earners. However, Medicaid is limited in its coverage and services in different states, causing inequality in healthcare delivery (Bridger et al., 2023). Patients with little or no health insurance are more likely to postpone or forego their treatments to protect their wallets, which means that they are likely to have poorer health than those insured. In particular, people with chronic diseases, such as diabetes, hypertension, and COPD, suffer from the absence of stable and accessible healthcare systems. Chronic disease, for instance, shows that the US has a higher neonatal mortality rate, as well as a higher infant mortality rate and a higher maternal mortality rate compared to the UK.

Low-income households, or those with chronic illnesses in the United States, experienced worse health outcomes than higher-income groups. This has been attributed to factors like poor access to preventive health services, cost of treatment, and more social stress. For instance, low-income patients who have diabetes may develop more severe complications, including kidney disease and lower limb amputation, due to inadequate and irregular care (Choi et al., 2020). Likewise, heart and respiratory diseases worsen if not checked frequently and treated as soon as possible. Therefore, the patients are diagnosed with high mortality rates and complications since they cannot afford the expensive drugs and medical costs; hence, they do not honor their treatment regimens.

It remains evident that through the universal coverage of the NHS, low-income earners can access necessary treatments for chronic illnesses without incurring direct out-of-pocket expenses. This results in improved care for chronic diseases and reduced complications and mortality rates. For instance, patients with low incomes and diagnosed with diabetes in the UK are more likely to visit clinics and get eye examinations, lowering the possibility of adverse effects. Hence, the UK records a relatively low diabetes mortality ratio compared to the US, a testimony to the healthcare systems that uphold equal access to facilities (Cazzaniga, 2022). Nevertheless, the goal of universal coverage is beneficial for the population, and the indicators of timely access to care still need to be improved for the NHS. Due to a lack of timely access to specialist appointments and treatment, chronic illnesses can worsen due to long waiting periods. However, the general framework of the NHS allows for improved access to care and better health for those with chronic conditions in the lower-income bracket.

There are comparative data on cancer survival rates, for instance, that indicate that the US has higher rates than the UK. For example, five-year survival rates for breast cancer are higher in the United States than in the United Kingdom. However, this is only half the picture since there are differences in insurance and health services utilization between men and women. Research has established that African Americans and other minorities in America have poorer cancer survival rates than their white counterparts because of disparities in insurance status and timely diagnosis (Cazzaniga, 2022). On the other hand, the analysis shows that the National Health Service ensures a similarly effective cancer treatment for patients with different socioeconomic statuses. Overall, some types of cancer may have worse survival in the UK, but the difference by income is less. Due to the universal coverage of the NHS, low-income earners can afford cancer screenings and treatments, hence the higher consistency between the two groups.

In the case of chronic illnesses such as diabetes and hypertension, the United States has its work cut out for it in ensuring equal access. Due to inadequate access to medications and preventive care, low-income persons are more susceptible to complications and mortality (Jacob, 2023). As the Institute of Medicine has noted, a lack of insurance leads to receiving care only when the condition is critical. The United Kingdom has a universal healthcare system, which, in most cases, can provide better results when treating chronic diseases among the less privileged. The described structure of the NHS enables people with chronic diseases to be checked up on frequently, thus minimizing the risks of developing critical conditions. For example, diabetes management in the UK involves daily check-ups and free access to drugs to control the disease and its complications in the long run.

The latest policies in the US have focused on enhancing health in low-income persons with chronic diseases. The Medicaid expansion under the ACA and the establishment of new community health centers have helped increase access to care. Similarly, the Chronic Care Management (CCM) and Patient-Centered Medical Homes (PCMH) programs are aimed at providing better and coordinated care for patients suffering from chronic diseases (Choi et al., 2020). However, political instabilities and variations during the program implementation at the state level can hinder these programs' usefulness and relevance. National Health Service, abbreviated as NHS in Great Britain, is a health care service consistently evolving to serve patients with chronic diseases. For instance, integrated care systems (ICS) aim to enhance the linkages of health and social care services. The NHS Long Term Plan defines measures to improve prevention strategies, early diagnosis, and treatment of chronic diseases, as well as improve health quality. Telemedicine and other advances like electronic health records are being deployed to enhance care and patient engagement. However, the challenges of the NHS include funding and the sustainability of the healthcare workforce.

In conclusion, the analysis of low-income population groups with chronic diseases in the US and UK highlights the significance of structural and funding differences in healthcare systems affecting the accessibility and quality of care. The US, despite spending a large amount of money on its healthcare, continues to face significant disparities because of its fragmented insurance system, which only provides a limited safety net to many low-income families and results in poor health outcomes. On the other hand, the UK-specific NHS provides more equal access to health services. Hence, managing and treating chronic diseases in the low-income population is more effective. Thus, the UK's priority for universal health access and social determinants shows a broader perspective on healthcare. However, both systems have their advantages and limitations where the focus of the NHS on equal access and equity is more efficient in addressing the issue of chronic diseases for vulnerable groups with low income. Therefore, The US can copy the UK model by increasing coverage and access to healthcare and tackling the social determinants of health. Much work still needs to be done on both parts to address their respective challenges that compromise the health of their people, especially those with chronic conditions who are more likely to be disadvantaged by systemic disadvantages.